These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 10147601)
1. Clinical experience with Albunex: a standard echocontrast agent for intravenous and intracoronary use. Cate FJ; Cornel JH; Widimsky P; Vletter W; Serruys P; Waaler A Am J Card Imaging; 1991 Sep; 5(3):217-23. PubMed ID: 10147601 [No Abstract] [Full Text] [Related]
2. [Assessment of left ventricular volume by contrast echocardiography]. Iwamori K; Ishikawa K Nihon Rinsho; 1998 Apr; 56(4):926-9. PubMed ID: 9577610 [TBL] [Abstract][Full Text] [Related]
3. Contrast echocardiography in coronary artery diseased patients: effect of systemic and pulmonary artery pressures on left heart opacification after intravenous injection of Albunex. Geny B; Piquard F; Muan B; Epailly E; Lambrechs M; Thiranos JC; Petit H; Eisenmann B; Haberey P Coron Artery Dis; 1997 Feb; 8(2):77-81. PubMed ID: 9211046 [TBL] [Abstract][Full Text] [Related]
4. Intracoronary albunex. Its effects on left ventricular hemodynamics, function, and coronary sinus flow in humans. Ten Cate FJ; Widimsky P; Cornel JH; Waldstein DJ; Serruys PW; Waaler A Circulation; 1993 Nov; 88(5 Pt 1):2123-7. PubMed ID: 8222106 [TBL] [Abstract][Full Text] [Related]
5. [Intrapulmonary arterial injection of Albunex for left heart contrast echocardiography]. Fukui O; Lim YJ; Nakatani D; Kawano S; Kodama K; Masuyama T; Asanuma H; Hori M; Mishima M J Cardiol; 1998 Feb; 31(2):99-107. PubMed ID: 9513037 [TBL] [Abstract][Full Text] [Related]
6. [Improved left ventricular endocardial detection by a first generation contrast agent. Effect of dose]. Vargas F; Hilbert G; Gruson D; Chene G; Journot V; Diebold B; Roudaut R Arch Mal Coeur Vaiss; 2000 Jan; 93(1):41-7. PubMed ID: 11227717 [TBL] [Abstract][Full Text] [Related]
7. Comparison of a new intravenous echo contrast agent (BY 963) with Albunex for opacification of left ventricular cavity. Leischik R; Beller KD; Erbel R Basic Res Cardiol; 1996; 91(1):101-9. PubMed ID: 8660247 [TBL] [Abstract][Full Text] [Related]
8. Left ventricular opacification by intravenous contrast echocardiography. Castini D; Gentile F; Ornaghi M; Mangiarotti E; Garbin M; Ravaglia R; Gioventù M; Mantero A; Corno R; Limido A; Morandi F; Fiorentini C; Pezzano A; Repetto S; Haider T; Morris H; Marelli C G Ital Cardiol; 1999 Jun; 29(6):620-9. PubMed ID: 10396665 [TBL] [Abstract][Full Text] [Related]
9. In vitro development and clinical applications of sonicated echo contrast agents. Voci P; Bilotta F; Scibilia G; Mercanti C; Caretta Q; Marino B; Reale A Am J Card Imaging; 1991 Sep; 5(3):192-9. PubMed ID: 10147599 [No Abstract] [Full Text] [Related]
10. [Assessment of myocardial perfusion with second harmonic imaging--using intravenous injection of Albunex and Levovist]. Hasegawa M; Saiki Y; Kayano H; Katagiri T Nihon Rinsho; 1998 Apr; 56(4):903-8. PubMed ID: 9577606 [TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients. Geny B; Mettauer B; Muan B; Bischoff P; Epailly E; Piquard F; Eisenmann B; Haberey P J Am Coll Cardiol; 1993 Oct; 22(4):1193-8. PubMed ID: 8409060 [TBL] [Abstract][Full Text] [Related]
12. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection. Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829 [TBL] [Abstract][Full Text] [Related]
13. Digital radiofrequency echocardiography in the detection of myocardial contrast following intravenous administration of Albunex. Monaghan MJ; Metcalfe JM; Odunlami S; Waaler A; Jewitt DE Eur Heart J; 1993 Sep; 14(9):1200-9. PubMed ID: 8223734 [TBL] [Abstract][Full Text] [Related]
14. The influence of Albunex on the pulmonary circulation in patients with pulmonary hypertension or left heart failure. Zotz RJ; Genth S; Mitrovic V; Waaler A; Erbel R; Meyer J Eur Heart J; 1996 Feb; 17(2):302-7. PubMed ID: 8732386 [TBL] [Abstract][Full Text] [Related]
15. Contrast opacification of left ventricular myocardium following intravenous administration of sonicated albumin microspheres. Sanders WE; Cheirif J; Desir R; Zoghbi WA; Hoyt BD; Schulz PE; Quiñones MA Am Heart J; 1991 Dec; 122(6):1660-5. PubMed ID: 1957761 [TBL] [Abstract][Full Text] [Related]
16. Increasing the dose and rate of Albunex infusion leads to superior left ventricular contrast effect. Dolan MS; Dent J; deFilippi C; Christopher T; Wible JH; Labovitz AJ J Am Soc Echocardiogr; 1998 May; 11(5):426-32. PubMed ID: 9619613 [TBL] [Abstract][Full Text] [Related]
17. Intracoronary and aortic root myocardial contrast echocardiography: the effect of route, dose, and pharmacologic coronary vasodilation. Bach DS; Armstrong WF; Collins T; Muller DW; Ramee SR; Bruns DE; Cheirif J J Am Soc Echocardiogr; 1995; 8(5 Pt 1):719-27. PubMed ID: 9417216 [TBL] [Abstract][Full Text] [Related]
18. The influence of intravenous Albunex injections on pulmonary arterial pressure, gas exchange, and left ventricular peak intensity. Walker R; Wiencek JG; Aronson S; Zaroff J; Glock D; Thisted R; Feinstein SB J Am Soc Echocardiogr; 1992; 5(5):463-70. PubMed ID: 1389214 [TBL] [Abstract][Full Text] [Related]
19. Sonicated albumin in exercise echocardiography: technique and feasibility to enhance endocardial visualization. Yvorchuk KJ; Sochowski RA; Chan KL J Am Soc Echocardiogr; 1996; 9(4):462-9. PubMed ID: 8827629 [TBL] [Abstract][Full Text] [Related]